Founded Date: 2012-01-01
Total Funding: 224000000.0
Employee Number: 101-250
Funding Status: IPO
Technology: Biotechnology, Health Care, Medical Device
Last Funding Type: Post-IPO Equity
Investors Number: 11.0
Last Funding Date: 2022-12-13
Industry: End-to-End Drug Development
Headquarters: Boston, Massachusetts, United States
Estimated Revenue: $1M to $10M